These investments include acquiring minority interests in CHG, expanding Cambridge Hospital in Jeddah by 68 beds, developing a 155-bed integrated care hospital in Riyadh and acquiring Cornerstone.

UAE – Amanat Holdings PJSC has expanded its healthcare operations into the UK after its wholly owned subsidiary, Cambridge Health Group (CHG), completed the acquisition of specialist care provider Cornerstone Healthcare Holdings Limited from UK private equity investor Ignite Growth LLP.
The acquisition gives CHG full ownership of Cornerstone, which operates four specialist care homes with 283 beds in southern England.
It also increases CHG’s combined capacity across its markets to more than 1,000 beds.
The transaction advances Amanat’s growth strategy, announced in July 2026, to invest approximately AED 1.5 billion (US$408.4 million) across its healthcare and education businesses.
The company targets a return on equity of at least 10% while expanding its operations and generating sustainable shareholder returns.
Amanat Chairman Dr Ali bin Harmal Aldhaheri said the company had completed or committed approximately AED 900 million (US$245.1 million), representing 60% of its investment target.
He said the Cornerstone acquisition strengthens CHG’s established presence in the UAE and Saudi Arabia while adding specialist care capabilities and opening access to the UK market.
Expansion of specialist healthcare services
Cornerstone provides care for people with complex dementia, progressive neurological conditions, severe mental illness, acquired brain injuries and rehabilitation needs.
Its operations benefit from established clinical expertise, an experienced workforce and relationships with NHS Integrated Care Boards and local authority commissioners.
The company has expanded its capacity in recent years, including the opening of The Burren, a 78-bed specialist care home in Bristol, in 2025.
Revenue from its existing facilities grew at a compound annual growth rate of nearly 10% over the past three years.
Cornerstone expects to generate approximately £36 million (US$48.2 million) in revenue and £7 million (US$9.4 million) in EBITDA in 2027.
Its growth plans include increasing occupancy at the Bristol facility, expanding into acquired brain injury and intermediate care services, and establishing facilities in additional locations.
The strategy builds on demand for specialist care in the UK and existing public-sector commissioning arrangements.
Investment terms and regional growth plans
The transaction carries an initial enterprise value of £71 million (US$95.1 million), with up to £5 million (US$6.7 million) in additional consideration linked to performance, bringing the potential total enterprise value to £76 million (US$101.8 million).
CHG funded the acquisition through internal resources and expects returns above its investment hurdle rate.
The deal follows CHG’s expansion from approximately 260 beds in 2021 to more than 700 licensed beds across the UAE and Saudi Arabia.
Its development pipeline includes a 68-bed expansion of Cambridge Hospital in Jeddah, adding rehabilitation and surgical services, and a planned 155-bed integrated care hospital in Riyadh.
Following the acquisition, Amanat has set a new medium-term target for CHG to exceed 1,500 beds through organic growth, new facility development and selective acquisitions.
Amanat Chief Executive Officer John Ireland said the transaction translates the company’s growth strategy into commercial and operational opportunities.
He noted that combining Cornerstone’s specialist expertise with CHG’s GCC operations would broaden its service portfolio and diversify its healthcare business.
Cornerstone’s existing management team, led by Chief Executive Officer Paul Hayes, will remain in place to oversee the business.
Be the first to leave a comment